Rodrigo Maranguape Silva da Cunha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rodrigo Maranguape Silva da Cunha has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Lissiana Magna Vasconcelos Aguiar
Faculty of Medicine, Federal University of Ceará, Sobral, Ceará, Brazil
3 shared publicationsThomas Dominik de Sousa dos Reis
Faculty of Medicine, Federal University of Ceará, Sobral, Ceará, Brazil
3 shared publicationsCarlos Franciney Moreira Vasconcelos
Biotechnology Core of Sobral, Molecular Biology Lab, State University of Acaraú Valley, Sobral, Brazil
2 shared publications- Carlos Franciney Moreira Vasconcelos
University of Medicine of Göttingen (UMG) Göttingen Germany
2 shared publications Frederico Bruno Mendes Batista Moreno
Department of Pharmacology, University of Fortaleza, Fortaleza, Brazil
2 shared publicationsJoão Garcia Alves Filho
Biotechnology Core of Sobral, Molecular Biology Lab, State University of Acaraú Valley, Sobral, Brazil
2 shared publications
Latest Publications
- 14 March 2024
- Published by Springer Nature in Plant Biosystems
- Vol. 158 (3) , 447-456
A comparative proteomic analysis between common cashew tree ( Anacardium occidentale L.) and early dwarf faga 11 ( Anacardium occidentale var. nanum ) seeds reveals exclusively expressed allergenic proteins
The cashew tree (Anacardium occidentale L.) is a crop of great importance for agriculture in semi-arid regions, contributing to the socioeconomic development of several regions of the world, includ...
- 14 March 2024
- Published by Springer Nature in Plant Biosystems
- Vol. 158 (3) , 447-456
A comparative proteomic analysis between common cashew tree ( Anacardium occidentale L.) and early dwarf faga 11 ( Anacardium occidentale var. nanum ) seeds reveals exclusively expressed allergenic proteins
The cashew tree (Anacardium occidentale L.) is a crop of great importance for agriculture in semi-arid regions, contributing to the socioeconomic development of several regions of the world, includ...
- 2 December 2022
- Published by Taylor & Francis in Free Radical Research
- Vol. 56 (11-12) , 760-770
Assessment of antioxidant and antiparkinsonian potential of a new diterpene isolated from Croton argyrophylloides
Oxidative stress is related to health problems including neurological and neurodegenerativedisturbs, such as Parkinson’s disease. Natural compounds are reported as source of antioxidant molecules. Therefore, this study aimed to analyze the antioxidant and neuroprotective potential of a new diterpene isolated from C. argyrophylloides (MP-1). Male Wistar rats (250–300 g) were used to evaluate MP-1 antiparkinsonian potential through neurodegenerative model induced by the neurotoxin 6-hydroxydopamine (21 μg). On the 14th day, animals were submitted to behavioral tests and on the 15th day, brain areas were dissected to neurochemical analyzes. MP-1 demonstrated a high antioxidant capacity in vitro and decreased the parkinsonian effects, such as behavioral changes, motor alterations, and body weight loss. MP-1 was also able to control the upregulated levels of nitrosative stress and lipid peroxidation. These findings suggest MP-1 as a diterpene with high antioxidant capacity which might be used to development of new approach against Parkinson’s disease. GRAPHICAL ABSTRACT
- 2 December 2022
- Published by Taylor & Francis in Free Radical Research
- Vol. 56 (11-12) , 760-770
Assessment of antioxidant and antiparkinsonian potential of a new diterpene isolated from Croton argyrophylloides
Oxidative stress is related to health problems including neurological and neurodegenerativedisturbs, such as Parkinson’s disease. Natural compounds are reported as source of antioxidant molecules. Therefore, this study aimed to analyze the antioxidant and neuroprotective potential of a new diterpene isolated from C. argyrophylloides (MP-1). Male Wistar rats (250–300 g) were used to evaluate MP-1 antiparkinsonian potential through neurodegenerative model induced by the neurotoxin 6-hydroxydopamine (21 μg). On the 14th day, animals were submitted to behavioral tests and on the 15th day, brain areas were dissected to neurochemical analyzes. MP-1 demonstrated a high antioxidant capacity in vitro and decreased the parkinsonian effects, such as behavioral changes, motor alterations, and body weight loss. MP-1 was also able to control the upregulated levels of nitrosative stress and lipid peroxidation. These findings suggest MP-1 as a diterpene with high antioxidant capacity which might be used to development of new approach against Parkinson’s disease. GRAPHICAL ABSTRACT
- 4 May 2021
- Published by Taylor & Francis in Free Radical Research
- Vol. 55 (5) , 556-568
Impact of eugenol onin vivomodel of 6-hydroxydopamine-induced oxidative stress
Oxidative stress is involved in many pathological disturbs, such as neurodegenerative disorders. Eugenol (Eug) is a phenolic compound with antioxidant and neuroprotective activities. Then, this study was conducted to investigate the potential neuroprotective effects of Eug on oxidative stress model induced by 6-hydroxydopamine (6-OHDA) in rats. First, the in vivo oxidative stress model was performed by intrastriatal injection (int.) of 6-OHDA (21 µg), followed by the treatment of Eug (0.1, 1, and 10 mg/kg/7 d) per os (p.o.). On the 7 d, behavioral tests were performed. On the 8 d, all the animals were euthanasied and their cerebral areas were excised for neurochemical and transcriptional analyses. The results showed that the treatment with Eug promoted neuroprotective effects on in vivo through reducing of oxidative stress and modulation of genes related to antioxidant activity. Furthermore, animals treated with Eug demonstrated returning of behavioral performance and body weight gain to normal conditions. Thus, this study reports the neuroprotective effects of Eug against oxidative stress induced by 6-OHDA in rats.
- 4 May 2021
- Published by Taylor & Francis in Free Radical Research
- Vol. 55 (5) , 556-568
Impact of eugenol onin vivomodel of 6-hydroxydopamine-induced oxidative stress
Oxidative stress is involved in many pathological disturbs, such as neurodegenerative disorders. Eugenol (Eug) is a phenolic compound with antioxidant and neuroprotective activities. Then, this study was conducted to investigate the potential neuroprotective effects of Eug on oxidative stress model induced by 6-hydroxydopamine (6-OHDA) in rats. First, the in vivo oxidative stress model was performed by intrastriatal injection (int.) of 6-OHDA (21 µg), followed by the treatment of Eug (0.1, 1, and 10 mg/kg/7 d) per os (p.o.). On the 7 d, behavioral tests were performed. On the 8 d, all the animals were euthanasied and their cerebral areas were excised for neurochemical and transcriptional analyses. The results showed that the treatment with Eug promoted neuroprotective effects on in vivo through reducing of oxidative stress and modulation of genes related to antioxidant activity. Furthermore, animals treated with Eug demonstrated returning of behavioral performance and body weight gain to normal conditions. Thus, this study reports the neuroprotective effects of Eug against oxidative stress induced by 6-OHDA in rats.
- 30 April 2020
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 127 (4) , 287-302
Eugenol and its association with levodopa in 6‐hydroxydopamine‐induced hemiparkinsonian rats: Behavioural and neurochemical alterations
Parkinson's disease is a neurodegenerative disorder that affects the central nervous system and is mainly characterized by the loss of dopaminergic neurons and pro‐oxidant mechanisms. Eugenol has been widely studied due to its anti‐inflammatory and antioxidant activities, making it a promising neuroprotective agent. This study aimed to investigate the effects of eugenol and its combined action with levodopa in the 6‐hydroxydopamine‐induced Parkinson's disease model. Wistar rats were subjected to intrastriatal injection of 6‐hydroxydopamine (21 μg) and then treated with eugenol (0.1, 1, or 10 mg/kg), levodopa (25 mg/kg) or their combination (eugenol 10 mg/kg + levodopa 12.5 mg/kg) orally for 14 days. On the 14th day, the animals were subjected to behavioural tests, and after euthanization and dissection of the brain areas, neurochemical analyses were performed. The results showed that eugenol reduced the oxidative stress and behavioural disturbances induced by 6‐hydroxydopamine. The eugenol and levodopa combination was more effective in some behavioural parameters and body‐weight gain in addition to promoting an increase in reduced glutathione levels compared to levodopa alone. Thus, the neuroprotective activity of eugenol was observed against motor and neurochemical disorders. Additionally, the eugenol and levodopa combination was promising when compared to conventional treatment.
- 30 April 2020
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 127 (4) , 287-302
Eugenol and its association with levodopa in 6‐hydroxydopamine‐induced hemiparkinsonian rats: Behavioural and neurochemical alterations
Parkinson's disease is a neurodegenerative disorder that affects the central nervous system and is mainly characterized by the loss of dopaminergic neurons and pro‐oxidant mechanisms. Eugenol has been widely studied due to its anti‐inflammatory and antioxidant activities, making it a promising neuroprotective agent. This study aimed to investigate the effects of eugenol and its combined action with levodopa in the 6‐hydroxydopamine‐induced Parkinson's disease model. Wistar rats were subjected to intrastriatal injection of 6‐hydroxydopamine (21 μg) and then treated with eugenol (0.1, 1, or 10 mg/kg), levodopa (25 mg/kg) or their combination (eugenol 10 mg/kg + levodopa 12.5 mg/kg) orally for 14 days. On the 14th day, the animals were subjected to behavioural tests, and after euthanization and dissection of the brain areas, neurochemical analyses were performed. The results showed that eugenol reduced the oxidative stress and behavioural disturbances induced by 6‐hydroxydopamine. The eugenol and levodopa combination was more effective in some behavioural parameters and body‐weight gain in addition to promoting an increase in reduced glutathione levels compared to levodopa alone. Thus, the neuroprotective activity of eugenol was observed against motor and neurochemical disorders. Additionally, the eugenol and levodopa combination was promising when compared to conventional treatment.
- Open Access
- 1 January 2019
- Published by Colegio Brasileiro de Reproducao Animal - CBRA in Animal Reproduction
- Vol. 16 (4) , 902-913
Evaluation of the proteomic profiles of ejaculated spermatozoa from Saanen bucks (Capra hircus)
Anim Reprod, vol.16, n4, p.902-913, 2019
- 1 January 2019
- Published by Colegio Brasileiro de Reproducao Animal - CBRA in Animal Reproduction
- Vol. 16 (4) , 902-913
Open AccessEvaluation of the proteomic profiles of ejaculated spermatozoa from Saanen bucks (Capra hircus)
Anim Reprod, vol.16, n4, p.902-913, 2019